Clinical trial
Phase 4 Study of Escitalopram Treatment and Biomarkers in Major Depressive Disorder
NCT01997580 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 4 Study of Escitalopram Treatment and Biomarkers in Major Depressive Disorder
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2013
- Completion date
- December 31, 2018
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.